Corixa

Corixa was a developer of immunotherapeutics with a focus on treating and preventing autoimmune diseases, cancer, and infectious diseases. Founded in 1994, the company conducted preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa had a broad technology platform that allowed for integrated vaccine design and the use of proprietary product components. Th...